Intraperitoneal Chemotherapy: The Lived Experiences of Taiwanese Patients With Ovarian Cancer.

Intraperitoneal Chemotherapy: The Lived Experiences of Taiwanese Patients With Ovarian Cancer.
Clin J Oncol Nurs. 2019 Dec 01;23(6):E100-E106
Authors: Chou JF, Lu Y
Abstract
BACKGROUND: Intraperitoneal (IP) chemotherapy is often a preferred treatment for ovarian cancer because of its clinical benefits, but research on the experiences of patients receiving IP chemotherapy is limited.
OBJECTIVES: The purpose of this article is to explore the lived experiences of Taiwanese patients diagnosed with ovarian cancer who have received at least one cycle of IP chemotherapy.
METHODS: A semistructured interview guide was used to collect data. Interviews were analyzed using a qualitative content analysis.
FINDINGS: The following themes emerged from the data.
PMID: 31730595 [PubMed - in process]

Source: Clinical Journal of Oncology Nursing - November 17, 2019 Category: Nursing Authors: Chou JF, Lu Y Tags: Clin J Oncol Nurs Source Type: research